Polysomnography in preterm infants and children with chronic lung disease
β Scribed by Sharon A. McGrath-Morrow; Timothy Ryan; Brian M. McGinley; Sande O. Okelo; Laura M. Sterni; J. Michael Collaco
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 88 KB
- Volume
- 47
- Category
- Article
- ISSN
- 8755-6863
No coin nor oath required. For personal study only.
β¦ Synopsis
Objective:
To determine the utility of overnight polysomnography (psg) in assessing pulmonary reserve in stable preterm children with chronic lung disease (cld).
Study design:
A retrospective review and descriptive study of overnight psgs and clinic visits of preterm infants/children less than 3 years of age who were diagnosed with bronchopulmonary dysplasia at discharge from the hospital and enrolled in the johns hopkins cld patient registry between 2008 and 2010.
Results:
Sixty-two clinically stable patients underwent at least one overnight polysomnogram for clinical indications. the majority of patients were referred for oxygen titration (71%). psgs from first studies revealed a mean respiratory disturbance index (rdi) of 8.2βΒ±β10.1 events/hr and a mean o(2) saturation (sao(2) ) nadir of 86.2βΒ±β5.7%. in patients who underwent more than one psg (nβ=β23), a significant decrease in rdi (pβ<β0.001) was found between the first study (mean age: 8.0βΒ±β3.3 months) and second study (mean age: 13.4βΒ±β5.2 months). outpatient clinical measures of mean room air sao(2) and respiratory rate were not predictive of psg measures of rdi and sao(2) nadir.
Conclusion:
Mean rdi was higher in stable preterm infants/children with cld compared to previously published controls. rdi decreased with age in stable preterm infants/children with cld suggesting improved pulmonary reserve with age. outpatient clinical measures (respiratory rate and room air sao(2) ) did not correlate with rdi and sao(2) nadir indicating that overnight psg is more sensitive in assessing pulmonary reserve than outpatient clinical measures.
π SIMILAR VOLUMES
Recent studies suggest that early dexamethasone therapy may lessen the pulmonary inflammation in preterm infants with respiratory distress syndrome (RDS). To investigate whether early (<12 hr) postnatal dexamethasone therapy would reduce the incidence of chronic lung disease (CLD), a randomized, dou
The purpose of this study was to compare the effects of daily inhaled beclomethasone (3 Γ 500 Β΅g) started on day 3 of life, with that of systemic dexamethasone (0.5 mg/kg/day) started between days 11-13 on clinical variables, lung inflammation, and pulmonary microvascular permeability in preterm inf